Human Î² cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes.
Cell Metab., Oct;16(4):435-48 (2012)
Identification of biomarkers to assess organ quality and predict posttransplantation outcomes.
Transplantation., Oct;94(8):851-8 (2012)
Naturally occurring immunoglobulin M (nIgM) autoantibodies prevent autoimmune diabetes and mitigate inflammation after transplantation.
Ann. Surg., Oct;256(4):634-41 (2012)
Improvement in outcomes of clinical islet transplantation: 1999-2010.
Diabetes Care., Jul;35(7):1436-45 (2012)
Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease.
J. Surg. Res., Aug;176(2):629-38 (2012)
Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.
J Transplant., 2011:637692 (2011)
Evolution of Î²-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation.
J Transplant., 2011:247959 (2011)
Evolution of Î²-Cell Replacement Therapy in Diabetes Mellitus: Pancreas Transplantation.
Diabetes Technol. Ther., Mar;13(3):395-418 (2011)
Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling.
Cell Calcium., 48(2-3):133-42 (2010 Aug-Sep)
Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection.
Cell Transplant., 19(5):597-612 (2010)
Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling.
J. Biol. Chem., Feb;285(8):5392-404 (2010)
Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation.
Am. J. Transplant., Aug;9(8):1846-52 (2009)
Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease.
Am. J. Transplant., Apr;9(4 Pt 2):894-906 (2009)
The use of stem cells in kidney disease.
Curr Opin Organ Transplant., Feb;14(1):72-8 (2009)
The use of stem cells in liver disease.
Curr Opin Organ Transplant., Feb;14(1):64-71 (2009)
Regenerative medicine and tissue engineering: contribution of stem cells in organ transplantation.
Curr Opin Organ Transplant., Feb;14(1):46-50 (2009)
Nocardiosis in a renal transplant recipient following rituximab preconditioning.
Ups. J. Med. Sci., 114(1):62-4 (2009)
Adenoviral graft-nephritis: case report and review of the literature.
Transpl. Int., Jun;22(6):672-7 (2009)
Salvage of hyperacute renal transplant hypoperfusion with stent placement: a case report.
J Vasc Interv Radiol., Dec;19(12):1761-1764.e2 (2008)
Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.
Endocr. Rev., Aug;29(5):603-30 (2008)